Using an artificial intelligence tool incorporating natural language processing to identify patients with a diagnosis of ANCA-associated vasculitis in electronic health records.

Autor: van Leeuwen JR; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine - Nephrology Section, Leiden University Medical Center, Leiden, the Netherlands., Penne EL; Department of Internal Medicine - Nephrology Section, Northwest Clinics, Alkmaar, the Netherlands., Rabelink T; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine - Nephrology Section, Leiden University Medical Center, Leiden, the Netherlands., Knevel R; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands., Teng YKO; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine - Nephrology Section, Leiden University Medical Center, Leiden, the Netherlands. Electronic address: Y.K.O.Teng@lumc.nl.

Publikováno v: Computers in biology and medicine [Comput Biol Med] 2024 Jan; Vol. 168, pp. 107757. Date of Electronic Publication: 2023 Nov 25.

Response to "Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation".

Autor: van Leeuwen JR; Center of Expertise for Lupus, Vasculitis- and Complement-mediated Systemic diseases, Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., Rabelink TJ; Center of Expertise for Lupus, Vasculitis- and Complement-mediated Systemic diseases, Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., Teng YKO; Center of Expertise for Lupus, Vasculitis- and Complement-mediated Systemic diseases, Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Kidney international reports [Kidney Int Rep] 2022 Nov 25; Vol. 8 (2), pp. 378. Date of Electronic Publication: 2022 Nov 25 (Print Publication: 2023).

Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Autor: van Leeuwen JR; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., Bredewold OW; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., van Dam LS; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., Werkman SL; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., Jonker JT; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands.; Department of Nephrology, Alrijne Ziekenhuis, Leiden, The Netherlands., Geelhoed M; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands., Langeveld APM; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department Otorhinolaryngology, Leiden University Medical Center, Leiden, The Netherlands., Remmelts HHF; Department of Nephrology, Meander Medisch Centrum, Amersfoort, The Netherlands., van den Broecke MM; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., Ray A; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., Rabelink TJ; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands., Teng YKO; Center of Expertise for Lupus-, Vasculitis- and Complement-mediated Systemic diseases (LuVaCs), Department of Internal Medicine-Nephrology Section, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Kidney international reports [Kidney Int Rep] 2021 Dec 08; Vol. 7 (3), pp. 624-628. Date of Electronic Publication: 2021 Dec 08 (Print Publication: 2022).